首页|Severe pediatric COVID-19:a review from the clinical and immunopathophysiological perspectives

Severe pediatric COVID-19:a review from the clinical and immunopathophysiological perspectives

扫码查看
Background Coronavirus disease 2019(COVID-19)tends to have mild presentations in children.However,severe and critical cases do arise in the pediatric population with debilitating systemic impacts and can be fatal at times,meriting further atten-tion from clinicians.Meanwhile,the intricate interactions between the pathogen virulence factors and host defense mecha-nisms are believed to play indispensable roles in severe COVID-19 pathophysiology but remain incompletely understood.Data sources A comprehensive literature review was conducted for pertinent publications by reviewers independently using the PubMed,Embase,and Wanfang databases.Searched keywords included"COVID-19 in children","severe pediatric COVID-19",and"critical illness in children with COVID-19".Results Risks of developing severe COVID-19 in children escalate with increasing numbers of co-morbidities and an unvac-cinated status.Acute respiratory distress stress and necrotizing pneumonia are prominent pulmonary manifestations,while various forms of cardiovascular and neurological involvement may also be seen.Multiple immunological processes are implicated in the host response to COVID-19 including the type Ⅰ interferon and inflammasome pathways,whose dysregu-lation in severe and critical diseases translates into adverse clinical manifestations.Multisystem inflammatory syndrome in children(MIS-C),a potentially life-threatening immune-mediated condition chronologically associated with COVID-19 exposure,denotes another scientific and clinical conundrum that exemplifies the complexity of pediatric immunity.Despite the considerable dissimilarities between the pediatric and adult immune systems,clinical trials dedicated to children are lacking and current management recommendations are largely adapted from adult guidelines.Conclusions Severe pediatric COVID-19 can affect multiple organ systems.The dysregulated immune pathways in severe COVID-19 shape the disease course,epitomize the vast functional diversity of the pediatric immune system and highlight the immunophenotypical differences between children and adults.Consequently,further research may be warranted to adequately address them in pediatric-specific clinical practice guidelines.

ImmunopathophysiologyMIS-CPediatric critical careSevere pediatric COVID-19

Yi-Kan Sun、Can Wang、Pei-Quan Lin、Lei Hu、Jing Ye、Zhi-Gang Gao、Ru Lin、Hao-Min Li、Qiang Shu、Li-Su Huang、Lin-Hua Tan

展开 >

Children's Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China

The Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310030,China

Surgical Intensive Care Unit,Children's Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China

Department of General Surgery,Children's Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China

Department of Cardiopulmonary and Extracorporeal Life Support,Children's Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China

Clinical Data Center,Children's Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China

Department of Cardiac Surgery,Children's Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China

National Clinical Research Center for Child Health,Children's Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China

Department of Infectious Diseases,Children's Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China

展开 >

Key Research and Development Program of Zhejiang

2023C03029

2024

世界儿科杂志(英文版)

世界儿科杂志(英文版)

CSTPCD
ISSN:
年,卷(期):2024.20(4)
  • 236